A long-standing collaboration between Stanford and IBM chemists has led to the development of a catalyst that could make biodegradable plastics derived from renewable materials promising alternatives to plastics made from oil.
The numbers of antibiotic-resistant bacteria are increasing globally, threatening human health. An undergraduate entrepreneurship program run by Stanford ChEM-H is helping students design and test new drugs to combat the resistant bacteria.
BY ROSEMARY MENA-WERTH
Latching chemotherapy drugs onto proteins that seek out tumors could provide a new way of treating tumors in the brain or with limited blood supply that are hard to reach with traditional chemotherapy.
When new cancer cells break free of their original tumor, they travel the blood system and land in distant organs to kindle new tumors. ChEM-H faculty fellow Jennifer Cochran and Amato Giaccia designed a decoy drug to prevent cancer's spread.
Stanford scientists have resurrected a discarded drug that helps human cells in a lab dish fight off two different viruses. Based on what they learned about how the drug works, it might also help fight the viruses that cause Ebola, dengue and Zika, among others.
When molecules won’t crystallize and technology confounds, who you gonna call? Marc Deller and the Stanford ChEM-H Macromolecular Structure Knoweldge Center are helping researchers from a broad range of backgrounds take advantage of the resources at the SLAC National Accelerator Laboratory to...
Chemical engineers at Stanford have discovered mechanical properties of the tear film on the eye's surface that can be used to manufacture contact lenses that more closely mimic the eye.
By Rosemary Mena-Werth
When contact lenses work really well, you forget they are on your eyes. You might not...
Ami Bhatt is mobilizing Stanford experts to fight the growing threat of cancer in the developing world.
By Ruthann Richter
As a child growing up in the United States, Ami Bhatt would frequently take trips with her parents back to their native country of India, where she saw a world altogether...
Catching a disease in its earliest stages can lead to more effective therapies. Stanford chemists have increased the likelihood of detecting these diseases via a test that is thousands of times more sensitive than current diagnostics.
By Bjorn Carey
A simple blood test that can accurately diagnose active tuberculosis could make it easier and cheaper to control a disease that kills 1.5 million people every year.
By Jennie Dusheck
Researchers at the Stanford University School of Medicine have identified a gene expression “signature” that...
Teasing apart subtle differences between a protein-shredding structure found in malaria parasites and in human cells enabled researchers to design a compound targeting the parasite without harming human tissue.
By Bruce Goldman
Stanford University School of Medicine investigators have...
Researchers have developed a new way to use atomic force microscopy to rapidly measure the mechanical properties of cells at the nanometer scale, an advance that could pave the way for better understanding immune disorders and cancer.
BY ANDREW MEYERS
A new tool enables researchers to test millions of mutated proteins in a matter of hours or days, speeding the search for new medicines, industrial enzymes and biosensors.
By Ramin Skibba
All living things require proteins, members of a vast family of molecules that nature "makes to order"...
Researchers stripped a virus of its infectious machinery and turned its benign core into a delivery vehicle that can target sick cells while leaving healthy tissue alone.
By Tom Abate
Stanford researchers have ripped the guts out of a virus and totally redesigned its core to repurpose its...
Stanford scientists produced a common cancer drug – previously only available from an endangered plant – in a common laboratory plant. This work could lead to a more stable supply of the drug and allow scientists to manipulate that drug to make it even safer and more effective.